Ms. Luosey has over 25 years of experience in product strategy, development operations, corporate planning, and program execution across multiple therapeutic areas and modalities, building program and alliance management functions supporting assets at every stage of drug development.

Most recently, Ms. Luosey served as Senior Vice President, Product and Development Operations at Anokion, leading cross-functional programs and its partnership with Pfizer, and previously as Vice President, Portfolio Strategy and Program Management at Replimune, where she established the program management function and R&D governance framework. Earlier, in senior program leadership roles at Cadent Therapeutics and Syntimmune, she led diligence and integration for several sell-side M&A transactions, including the acquisitions of Cadent (by Novartis) and Syntimmune (by Alexion).
Ms. Luosey is a certified Project Management Professional (PMP) and holds an M.S. in Project Management from Boston University and a B.F.A. from the University of Hartford.